Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05803096 · ClinicalTrials.gov registry record · Phase 4
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
A Phase 4 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 143
- Enrollment target
NCT05803096 is a Phase 4 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 143 participants.
The verdict
NCT05803096, a Phase 4 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 143 participants
- Enrollment target
Study Summary
Transrectal prostate biopsy is a commonly performed ambulatory procedure for diagnosing prostate cancer. Prostate biopsy are associated with pain or anxiety. Nitrous oxide (or laughing gas) is a well-known inhaled anesthetic which is frequently used in dental offices and for pediatric procedures to alleviate a patient's anxiety and pain. This study seeks to determine whether administration of nitrous oxide at the time of prostate biopsy will improve a patient's experience of care.
Interventions
- OTHER Oxygen
- DRUG Self-Administered Nitrous Oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2021-12-12 |
| Est. Completion | 2022-09-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05803096
The ClinicalTrials.gov registry entry for NCT05803096 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxygen is the first listed.
NCT05803096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05803096 about?
NCT05803096 is a clinical study titled "Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain". Transrectal prostate biopsy is a commonly performed ambulatory procedure for diagnosing prostate cancer. Prostate biopsy are associated with pain or anxiety. Nitrous oxide (or laughing gas) is a well-known inhaled anesthetic which is frequently used in dental offices and for pediatric procedures to ...
What is the current status of trial NCT05803096?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 143 participants. The study started on 2021-12-12. Estimated completion is 2022-09-09.
What interventions are being tested in trial NCT05803096?
The interventions under investigation include: Oxygen (OTHER), Self-Administered Nitrous Oxide (DRUG).
Who is sponsoring clinical trial NCT05803096?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.